Development of Glypican 3-Targeting Antibody-Drug Conjugates for Hepatocellular Carcinoma Therapy.

Li N, Zeng Y, Xiong X, Zhang P, Peng X, Chen W, Wei W, Xia X, Liu R, Lu Y, Geng M, Lan X, Li X, Yuan T, Huang Y, Xiao Y, Mou Z, Yie J.

Open source

DOI: 10.1158/2767-9764.crc-26-0139
Published: 2026-07-01
Container: Cancer Res Commun
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1158/2767-9764.crc-26-0139,
  title = {Development of Glypican 3-Targeting Antibody-Drug Conjugates for Hepatocellular Carcinoma Therapy.},
  author = {Li N and  Zeng Y and  Xiong X and  Zhang P and  Peng X and  Chen W and  Wei W and  Xia X and  Liu R and  Lu Y and  Geng M and  Lan X and  Li X and  Yuan T and  Huang Y and  Xiao Y and  Mou Z and  Yie J.},
  year = {2026},
  journal = {Cancer Res Commun},
  doi = {10.1158/2767-9764.crc-26-0139},
  url = {https://doi.org/10.1158/2767-9764.crc-26-0139}
}

RIS

TY  - JOUR
TI  - Development of Glypican 3-Targeting Antibody-Drug Conjugates for Hepatocellular Carcinoma Therapy.
AU  - Li N
AU  -  Zeng Y
AU  -  Xiong X
AU  -  Zhang P
AU  -  Peng X
AU  -  Chen W
AU  -  Wei W
AU  -  Xia X
AU  -  Liu R
AU  -  Lu Y
AU  -  Geng M
AU  -  Lan X
AU  -  Li X
AU  -  Yuan T
AU  -  Huang Y
AU  -  Xiao Y
AU  -  Mou Z
AU  -  Yie J.
PY  - 2026
JO  - Cancer Res Commun
DO  - 10.1158/2767-9764.crc-26-0139
UR  - https://doi.org/10.1158/2767-9764.crc-26-0139
ER  -

APA

N, L., Y, Z., X, X., P, Z., X, P., W, C., W, W., X, X., R, L., Y, L., M, G., X, L., X, L., T, Y., Y, H., Y, X., Z, M., & J., Y. (2026). Development of Glypican 3-Targeting Antibody-Drug Conjugates for Hepatocellular Carcinoma Therapy.. Cancer Res Commun. https://doi.org/10.1158/2767-9764.crc-26-0139

Source records

europe-pmc · retrieved 2026-11-10T14:17:12.268Z